What you need to know about stomach cancer
(HealthDay)—New treatment options are giving hope to patients with stomach cancer.
Nov 25, 2021
0
14
(HealthDay)—New treatment options are giving hope to patients with stomach cancer.
Nov 25, 2021
0
14
One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the ...
Nov 19, 2021
0
21
A microfilter device that can easily separate and capture trace amounts of cancer cells in blood has been developed by a Kumamoto University research group. The palm-sized device is expected to contribute to the development ...
Jun 29, 2021
0
3
The first thing to know is: The COVID vaccines are safe, effective, and necessary. Doctors recommend them and the vaccines are available to everyone ages 12 and older in New York state.
Jun 8, 2021
0
7
An advanced imaging approach developed at the University of Virginia School of Medicine could let surgeons determine the best target in the brain to stop epilepsy seizures, new research suggests.
Apr 26, 2021
0
6
New biomarkers for Alzheimer's disease are a priority area for researchers seeking to learn more about the disease and find possible methods of early diagnosis. Researchers at Karolinska Institutet in Sweden have now studied ...
Apr 22, 2021
1
32
Getting a mammogram or other cancer check soon after a COVID-19 vaccination? Be sure to tell the doctor about the shot to avoid false alarm over a temporary side effect.
Mar 5, 2021
0
107
(HealthDay)—A special calorie-burning type of body fat appears to help protect against an array of chronic ailments, including heart disease, type 2 diabetes and high blood pressure, a new study suggests.
Jan 11, 2021
0
9
(HealthDay)—The U.S. Food and Drug Administration approved the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer, the agency ...
Dec 3, 2020
0
3
Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to recent research out of the University of Alberta.
Oct 20, 2020
0
20